Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Bone marrow stem cell transplantation feasible, safe treatment for children with severe traumatic brain injury

Bone marrow stem cell transplantation feasible, safe treatment for children with severe traumatic brain injury

Acupressure improves cognitive function in patients with mild traumatic brain injury

Acupressure improves cognitive function in patients with mild traumatic brain injury

Amphetamine linked to development of Parkinson’s disease

Amphetamine linked to development of Parkinson’s disease

RegeneRx listed on MDB’s 'Best & Brightest' innovators for 2011

RegeneRx listed on MDB’s 'Best & Brightest' innovators for 2011

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

Pittsburgh researchers awarded funds for testing brain-computer interfaces in patients with spinal cord injuries

Research: 75% of nonmilitary group medically evacuated for nonbattle injuries did not return to field

Research: 75% of nonmilitary group medically evacuated for nonbattle injuries did not return to field

Ski helmets prevent head injuries by 35%: Study

Ski helmets prevent head injuries by 35%: Study

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

New research: Motorcycle helmets appear to reduce cervical spine injury

New research: Motorcycle helmets appear to reduce cervical spine injury

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

Motorcycle helmets reduce spine injuries after collisions

Motorcycle helmets reduce spine injuries after collisions

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

VA announces first Ai2 awards under Industry Innovation Competition

VA announces first Ai2 awards under Industry Innovation Competition

North Shore-LIJ begins patient enrollment in epilepsy research study

North Shore-LIJ begins patient enrollment in epilepsy research study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.